A broad range of Fab stabilities within a host of therapeutic IgGs.

Although the functional properties of IgGs are well known, little has been published concerning the stability of whole IgG molecules. Stability is, however, a requirement for the development of antibodies for therapeutic or diagnostic applications. The hypervariable antigen-binding region (Fv) is responsible for stability variations between IgGs of identical subclass. To determine the range of stabilities that may be expected for human(ized) antibodies, differential scanning calorimetry was performed on 17 human(ized) antibodies from various in-house programs. The antigen-binding fragments (Fabs) of these antibodies exhibited thermal unfolding transitions with midpoints (T(M)s) varying from 57 to 82 degrees C. Antibodies with very low Fab stabilities were found to aggregate and express poorly. Fab instability was often associated with high levels of uncommonly observed amino acids or CDR loop lengths particularly within the variable heavy chain domain. Overall, the study provides a thermostability range for IgGs and suggests possible stability guidelines for developing antibody diagnostics or therapeutics.

[1]  A. Plückthun,et al.  Engineered turns of a recombinant antibody improve its in vivo folding. , 1995, Protein engineering.

[2]  Garrett M. Morris,et al.  Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design , 2001, Science.

[3]  P. Carter,et al.  Engineering antibodies for imaging and therapy. , 1997, Current opinion in biotechnology.

[4]  A. Sarai,et al.  Comparative thermodynamic analyses of the Fv, Fab* and Fab and Fab fragments of anti‐dansyl mouse monoclonal antibody , 1995 .

[5]  L. Presta,et al.  Antigen binding thermodynamics and antiproliferative effects of chimeric and humanized anti-p185HER2 antibody Fab fragments. , 1992, Biochemistry.

[6]  H R Hoogenboom,et al.  Design and application of diabodies, triabodies and tetrabodies for cancer targeting. , 2001, Journal of immunological methods.

[7]  I. Pastan,et al.  Antibody engineering of recombinant Fv immunotoxins for improved targeting of cancer: disulfide-stabilized Fv immunotoxins. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  A. Vermeer,et al.  The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein. , 2000, Biophysical journal.

[9]  N. Carter,et al.  Human immunoglobulin VH and D segments on chromosomes 15q11.2 and 16p11.2. , 1994, Human molecular genetics.

[10]  C. Pace,et al.  How to measure and predict the molar absorption coefficient of a protein , 1995, Protein science : a publication of the Protein Society.

[11]  A. Chumanevich,et al.  Antiferritin single‐chain antibody: a functional protein with incomplete folding? , 1998, FEBS letters.

[12]  Jérôme Lane,et al.  IMGT®, the international ImMunoGeneTics information system® , 2004, Nucleic Acids Res..

[13]  A. Meindl,et al.  The Vϰ gene repertoire in the human germ line , 1990 .

[14]  A. Plückthun,et al.  Stability engineering of antibody single-chain Fv fragments. , 2001, Journal of molecular biology.

[15]  D. Moinier,et al.  Human immunoglobulin VH and VK repertoire revealed by in situ hybridization. , 1990, Molecular immunology.

[16]  Andreas Plückthun,et al.  Biophysical properties of human antibody variable domains. , 2003, Journal of molecular biology.

[17]  I. Tomlinson,et al.  Somatic insertions and deletions shape the human antibody repertoire. , 1999, Journal of molecular biology.

[18]  S. Steinbacher,et al.  Sequence statistics reliably predict stabilizing mutations in a protein domain. , 1994, Journal of molecular biology.

[19]  M. Lefranc,et al.  Sequence and evolution of the human germline V lambda repertoire. , 1996, Journal of molecular biology.

[20]  E L Sonnhammer,et al.  The imprint of somatic hypermutation on the repertoire of human germline V genes. , 1996, Journal of molecular biology.

[21]  M. Hurle,et al.  Protein engineering techniques for antibody humanization. , 1994, Current opinion in biotechnology.

[22]  D. Röthlisberger,et al.  Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability. , 2005, Journal of molecular biology.

[23]  Valérie Barbié,et al.  The Human Immunoglobulin Kappa Variable (IGKV) Genes and Joining (IGKJ) Segments , 1998, Experimental and Clinical Immunogenetics.

[24]  P. Brams,et al.  In vitro IgE inhibition in B cells by anti-CD23 monoclonal antibodies is functionally dependent on the immunoglobulin Fc domain. , 2000, International journal of immunopharmacology.

[25]  I. Tomlinson,et al.  The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. , 1992, Journal of molecular biology.

[26]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[27]  I. Tomlinson,et al.  A directory of human germ‐line Vχ segments reveals a strong bias in their usage , 1994 .

[28]  Boris Steipe,et al.  Consensus-based engineering of protein stability: from intrabodies to thermostable enzymes. , 2004, Methods in enzymology.

[29]  E. H. Cohen,et al.  Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity , 2005, Nature Biotechnology.

[30]  R M Hoet,et al.  Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. , 1999, Journal of molecular biology.

[31]  P Leder,et al.  The genetics of antibody diversity. , 1982, Scientific American.

[32]  H. Hoogenboom,et al.  Selecting and screening recombinant antibody libraries , 2005, Nature Biotechnology.

[33]  T. T. Wu,et al.  AN ANALYSIS OF THE SEQUENCES OF THE VARIABLE REGIONS OF BENCE JONES PROTEINS AND MYELOMA LIGHT CHAINS AND THEIR IMPLICATIONS FOR ANTIBODY COMPLEMENTARITY , 1970, The Journal of experimental medicine.

[34]  Marie-Paule Lefranc,et al.  IMGT, the international ImMunoGeneTics database , 2001, Nucleic Acids Res..

[35]  S Minoshima,et al.  One-megabase sequence analysis of the human immunoglobulin lambda gene locus. , 1997, Genome research.

[36]  A. Plückthun,et al.  Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. , 2000, Journal of molecular biology.

[37]  J. L. López-Lacomba,et al.  Differential scanning calorimetry of the irreversible thermal denaturation of thermolysin. , 1988, Biochemistry.

[38]  B. E. Kimmel,et al.  Engineering stability into Escherichia coli secreted Fabs leads to increased functional expression. , 2006, Protein engineering, design & selection : PEDS.

[39]  A. Plückthun,et al.  The hierarchy of mutations influencing the folding of antibody domains in Escherichia coli. , 1999, Protein engineering.

[40]  Andreas Plückthun,et al.  Stability improvement of antibodies for extracellular and intracellular applications: CDR grafting to stable frameworks and structure-based framework engineering. , 2004, Methods.

[41]  Marie-Paule Lefranc,et al.  The Human Immunoglobulin Heavy Variable Genes , 1999, Experimental and Clinical Immunogenetics.

[42]  Lucy J. Holt,et al.  Domain antibodies: proteins for therapy. , 2003, Trends in biotechnology.

[43]  S. Demarest,et al.  Optimization of the antibody C(H)3 domain by residue frequency analysis of IgG sequences. , 2004, Journal of molecular biology.

[44]  S. Demarest,et al.  An Intermediate pH Unfolding Transition Abrogates the Ability of IgE to Interact with Its High Affinity Receptor FcϵRIα* , 2006, Journal of Biological Chemistry.

[45]  Z. Peng,et al.  Consensus-derived structural determinants of the ankyrin repeat motif , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[46]  T. Honjo,et al.  Organization of the Human Immunoglobulin Heavy-Chain Locus , 1996 .